Patents by Inventor Maryse Belleville

Maryse Belleville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Long-acting theophylline in medicinal form
    Patent number: 4512994
    Abstract: Long-acting forms of theophylline for use in treating asthma comprise theophylline associated with a compound of the substituted cinnamamide type of the general formula ##STR1## wherein R is hydrogen, a hologen or an acetyl radical; R.sub.1 is hydrogen or the methyl radical; R.sub.2 is ##STR2## wherein R.sub.3 is hydrogen or the methyl radical; or R.sub.1 and R.sub.2 together with the adjacent nitrogen tom form the 2,2-dimethyl-3-oxazolidinyl group.
    Type: Grant
    Filed: May 3, 1983
    Date of Patent: April 23, 1985
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Michel Bayssat, Maryse Belleville, Marcel Grand
  • Prolonged-release pharmaceutical compositions for oral administration, their methods of making and use
    Patent number: 4155993
    Abstract: An orally administrable pharmaceutical composition comprises a dosage of the acid oralate of naftidrofuryl having a prolonged release coating which is a film formed from hydroxypropyl methyl cellulose and ethyl cellulose, the content of ethyl cellulose being between 30 and 50% and containing 8 to 15% of propylene glycol relative to the total of the cellulose derivatives.The composition, having prolonged therapeutic activity is capable of being used in the treatment of arterial diseases in limbs, circulatory disorders in the hands and feet, cerebral vascular disorders and diffuse circulatory insufficiency with elderly people.
    Type: Grant
    Filed: January 13, 1978
    Date of Patent: May 22, 1979
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Maryse Belleville, Francoise Merle, Jean-Claude Lechevin